Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adele K Fielding

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 23, 2020
Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles VirusSarah Aref, Anna Z Castleton, Katharine Bailey, et al.
Genes, Chromosomes & Cancer|May 3, 2021
Single nucleotide polymorphism array-based signature of low hypodiploidy in acute lymphoblastic leukemiaThomas Creasey, Amir Enshaei, Karin Nebral, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 24, 2011
Differential cytopathology and kinetics of measles oncolysis in two primary B-cell malignancies provides mechanistic insightsBella Patel, Aditi Dey, Ehsan Ghorani, et al.
Blood|May 15, 2014
Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biologyBella Patel, Aditi Dey, Anna Z Castleton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2017
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter StudyGiovanni Martinelli, Nicolas Boissel, Patrice Chevallier, et al.
Frontiers in Pharmacology|March 27, 2020
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content ValidityPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Therapeutic Advances in Hematology|October 26, 2020
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative studyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
British Journal of Haematology|October 30, 2009
Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993Bella Patel, Lena Rai, Georgina Buck, et al.
The Journal of Allergy and Clinical Immunology|September 21, 2011
Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiencyMarta Rizzi, Carla Neumann, Adele K Fielding, et al.
British Journal of Haematology|June 26, 2020
Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19Andrew J Wilson, Ethan Troy-Barnes, Maryam Subhan, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 23, 2020
Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles VirusSarah Aref, Anna Z Castleton, Katharine Bailey, et al.
Genes, Chromosomes & Cancer|May 3, 2021
Single nucleotide polymorphism array-based signature of low hypodiploidy in acute lymphoblastic leukemiaThomas Creasey, Amir Enshaei, Karin Nebral, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 24, 2011
Differential cytopathology and kinetics of measles oncolysis in two primary B-cell malignancies provides mechanistic insightsBella Patel, Aditi Dey, Ehsan Ghorani, et al.
Blood|May 15, 2014
Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biologyBella Patel, Aditi Dey, Anna Z Castleton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2017
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter StudyGiovanni Martinelli, Nicolas Boissel, Patrice Chevallier, et al.
Frontiers in Pharmacology|March 27, 2020
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content ValidityPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Therapeutic Advances in Hematology|October 26, 2020
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative studyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
British Journal of Haematology|October 30, 2009
Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993Bella Patel, Lena Rai, Georgina Buck, et al.
The Journal of Allergy and Clinical Immunology|September 21, 2011
Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiencyMarta Rizzi, Carla Neumann, Adele K Fielding, et al.
British Journal of Haematology|June 26, 2020
Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19Andrew J Wilson, Ethan Troy-Barnes, Maryam Subhan, et al.
Pageof 9